LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1Shanghai Minbiotech
03 1Alembic Pharmaceuticals Limited
04 1Alfa Chemistry
05 1Anax Laboratories
06 1Aspen Bio
07 1Beijing Sjar Technology Development
08 1Biotechnica DWC
09 1Cipla
10 1DEAFARMA
11 1Guangdong Raffles PharmaTech Co Ltd
12 1Guangzhou Tosun Pharmaceutical
13 1Hangzhou Longshine Bio-Tech
14 1Hetero Drugs
15 1Hunan Huateng Pharmaceutical Co ltd
16 1Lunan Pharmaceutical
17 2MSN Laboratories
18 1Mac-Chem Products (India) Pvt.Ltd
19 1Morepen Laboratories
20 1Sakar Healthcare
21 1Shenzhen HwaGen Pharmaceutical
22 1Shilpa Medicare
23 1Sichuan Qingmu Pharmaceutical
24 1Synthon Pharmaceuticals
25 1Tecoland Corporation
26 1Wisdom Pharmaceutical
27 1Zhejiang Jiuzhou Pharmaceutical
Reset all filters
01 1Algeria
02 11China
03 11India
04 1Italy
05 1Netherlands
06 3U.S.A
Reset all filters
01 6Active
02 22Blank
01 28Blank
Reset all filters
01 28Blank
Reset all filters
01 1WC-0041
02 1WC-0082
03 1WC-0147
04 1WC-0349
05 24Blank
Reset all filters
01 28Blank
Reset all filters
01 154893-0032
02 154893-0043
03 182920-028
04 25Blank
01 28Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39323
Submission : 2023-12-27
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-06-27
Pay. Date : 2023-02-06
DMF Number : 37971
Submission : 2023-02-02
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-02-05
Pay. Date : 2015-12-23
DMF Number : 30104
Submission : 2015-12-24
Status : Active
Type : II
Date of Issue : 2022-07-27
Valid Till : 2025-07-02
Written Confirmation Number : WC-0147
Address of the Firm :
NDC Package Code : 82920-028
Start Marketing Date : 2022-08-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-04-15
Pay. Date : 2015-10-29
DMF Number : 29918
Submission : 2015-10-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-12-18
Pay. Date : 2015-09-23
DMF Number : 29672
Submission : 2015-09-29
Status : Active
Type : II
Date of Issue : 2022-09-02
Valid Till : 2025-05-05
Written Confirmation Number : WC-0349
Address of the Firm :
NDC Package Code : 54893-0043
Start Marketing Date : 2016-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-09-16
Pay. Date : 2016-07-01
DMF Number : 30341
Submission : 2016-03-04
Status : Active
Type : II
NDC Package Code : 54893-0032
Start Marketing Date : 2014-12-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-07-16
Valid Till : 2025-08-08
Written Confirmation Number : WC-0041
Address of the Firm :
Date of Issue : 2022-06-17
Valid Till : 2025-02-07
Written Confirmation Number : WC-0082
Address of the Firm :
94
PharmaCompass offers a list of Axitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Axitinib manufacturer or Axitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Axitinib manufacturer or Axitinib supplier.
PharmaCompass also assists you with knowing the Axitinib API Price utilized in the formulation of products. Axitinib API Price is not always fixed or binding as the Axitinib Price is obtained through a variety of data sources. The Axitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Axitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Axitinib, including repackagers and relabelers. The FDA regulates Axitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Axitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Axitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Axitinib supplier is an individual or a company that provides Axitinib active pharmaceutical ingredient (API) or Axitinib finished formulations upon request. The Axitinib suppliers may include Axitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Axitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 27 companies offering Axitinib
Get in contact with the supplier of your choice: